← Back to signals
PFE
STRONG BUYPfizer Inc.
Health Care
0.62
PEGY ratio
Rank #60
Why This Matters
This stock appears significantly undervalued relative to its growth and dividend yield. Strong projected growth of 116.6% annually over 5 years. Attractive dividend yield of 6.7%.
PFE is trading at 19.6x earnings against 25.0% capped growth (actual 116.6%) + 6.7% yield, giving a PEGY of 0.62. The math suggests the stock is significantly undervalued relative to its growth and income profile.
~ Growth estimate uses historical CAGR (forward estimates unavailable)
- • Growth rate derived from historical CAGR — limited analyst coverage.
- • Growth rate capped at 25% for PEGY calculation (actual: 116.6%). Per Peter Lynch methodology, growth above 25% is rarely sustainable over 5 years.
Scan date: 2026-06-02
Valuation
19.6x
P/E Ratio
Growth
116.6%
5yr EPS
Income
6.7%
Div Yield
PEGY Components
PEGY Score0.62
Denominator31.7%
EPS (TTM)$1.31
Market Data
Price$25.63
ExchangeNYSE
S&P 500
What Changed
PEGY Score
0.62→0.62(-0.01)
Rank
#70→#60(+10 positions)
vs 7 days ago
Portfolio Context
Founder does not hold this stock.
Not in your portfolio.
Sector: Health Care
PEGY History — 90 days
Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only